Home Page
03:30:25 EDT Sat 23 Aug 2014
Enter Symbol
or Name
USA
CA



HOLOGIC INC
Symbol U : HOLX
Recent Sedar Documents

Hologic Announces Expiration of 6.25% Senior Notes Exchange Offer

2013-03-22 17:59 ET - News Release

BEDFORD, Mass., March 22, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the expiration of its offer to exchange (the Exchange Offer) up to $1 billion aggregate principal amount of its 6.25% Senior Notes due 2020 which have been registered under the Securities Act of 1933, as amended (the Exchange Notes), for up to $1 billion of the Company's outstanding 6.25% Senior Notes due 2020, which were issued on August 1, 2012 in a private placement (the Old Notes). The Exchange Notes have substantially identical terms to the Old Notes. The Exchange Offer expired at 5:00 p.m. Eastern Time, on March 22, 2013.

Wells Fargo Bank, National Association, the exchange agent for the Exchange Offer, has advised that Old Notes in the aggregate principal amount of $994,130,000, representing 99.41% of the aggregate principal amount, were validly tendered and not validly withdrawn prior to the expiration of the Exchange Offer. The Company has accepted for exchange all of the validly tendered Old Notes, and expects to issue the Exchange Notes on or about March 27, 2013.

This press release is for informational purposes only and is neither an offer to exchange, nor a solicitation of an offer to sell, the Exchange Notes. The Exchange Offer was made pursuant to the prospectus dated February 21, 2013.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products. The Company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com.

     

Contacts:        

Deborah Gordon       

David Cross


Vice President, Investor Relations          

Vice President & Treasurer


(781) 999-7716                                                         

(781) 999-7789


deborah.gordon@hologic.com          

david.cross@hologic.com





Al Kildani



Senior Director, Investor Relations  



(858) 410-8653 



al.kildani@hologic.com


 

 

SOURCE Hologic, Inc.

© 2014 Canjex Publishing Ltd. All rights reserved.